

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 9.37970885 |
| 2 | desmosome organization (GO:0002934) | 9.34492708 |
| 3 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.18954344 |
| 4 | establishment of skin barrier (GO:0061436) | 5.89465888 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.89460681 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.89460681 |
| 7 | regulation of water loss via skin (GO:0033561) | 5.75150821 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.16203426 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.97600253 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.89353627 |
| 11 | negative T cell selection (GO:0043383) | 4.87130909 |
| 12 | cell-substrate junction assembly (GO:0007044) | 4.86210091 |
| 13 | multicellular organismal water homeostasis (GO:0050891) | 4.78033856 |
| 14 | keratinocyte proliferation (GO:0043616) | 4.75943255 |
| 15 | positive T cell selection (GO:0043368) | 4.73868083 |
| 16 | surfactant homeostasis (GO:0043129) | 4.70273949 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.65844417 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.65233464 |
| 19 | negative thymic T cell selection (GO:0045060) | 4.62743125 |
| 20 | thymic T cell selection (GO:0045061) | 4.60555597 |
| 21 | T cell selection (GO:0045058) | 4.48320622 |
| 22 | keratinization (GO:0031424) | 4.30903853 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.26009432 |
| 24 | negative regulation of cell killing (GO:0031342) | 4.26009432 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.04786774 |
| 26 | water homeostasis (GO:0030104) | 3.90962803 |
| 27 | atrioventricular valve morphogenesis (GO:0003181) | 3.66343577 |
| 28 | chemical homeostasis within a tissue (GO:0048875) | 3.63096829 |
| 29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.57092078 |
| 30 | alpha-linolenic acid metabolic process (GO:0036109) | 3.56408328 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 3.52913528 |
| 32 | interferon-gamma production (GO:0032609) | 3.52860309 |
| 33 | keratinocyte differentiation (GO:0030216) | 3.52662959 |
| 34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.49751908 |
| 35 | L-phenylalanine catabolic process (GO:0006559) | 3.49751908 |
| 36 | L-phenylalanine metabolic process (GO:0006558) | 3.44490897 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.44490897 |
| 38 | regulation of cholesterol homeostasis (GO:2000188) | 3.42652591 |
| 39 | epithelial cell-cell adhesion (GO:0090136) | 3.42270259 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.39922117 |
| 41 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.34989696 |
| 42 | urea metabolic process (GO:0019627) | 3.31349002 |
| 43 | urea cycle (GO:0000050) | 3.31349002 |
| 44 | peptide cross-linking (GO:0018149) | 3.30497604 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.29175498 |
| 46 | regulation of endothelial cell chemotaxis (GO:2001026) | 3.28293128 |
| 47 | T cell receptor signaling pathway (GO:0050852) | 3.27661020 |
| 48 | aromatic amino acid family catabolic process (GO:0009074) | 3.24621932 |
| 49 | negative regulation of fibrinolysis (GO:0051918) | 3.21093610 |
| 50 | response to interleukin-15 (GO:0070672) | 3.20578337 |
| 51 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.20341229 |
| 52 | kynurenine metabolic process (GO:0070189) | 3.16053562 |
| 53 | valine metabolic process (GO:0006573) | 3.12602181 |
| 54 | indole-containing compound catabolic process (GO:0042436) | 3.12040720 |
| 55 | indolalkylamine catabolic process (GO:0046218) | 3.12040720 |
| 56 | tryptophan catabolic process (GO:0006569) | 3.12040720 |
| 57 | semaphorin-plexin signaling pathway (GO:0071526) | 3.12005287 |
| 58 | phospholipid efflux (GO:0033700) | 3.09882659 |
| 59 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.09530863 |
| 60 | complement activation, alternative pathway (GO:0006957) | 3.06351152 |
| 61 | positive regulation of tolerance induction (GO:0002645) | 3.05680792 |
| 62 | cell-substrate adherens junction assembly (GO:0007045) | 3.03948948 |
| 63 | focal adhesion assembly (GO:0048041) | 3.03948948 |
| 64 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.99558801 |
| 65 | epidermis development (GO:0008544) | 2.97192290 |
| 66 | gap junction assembly (GO:0016264) | 2.97051850 |
| 67 | bile acid biosynthetic process (GO:0006699) | 2.96163255 |
| 68 | renal filtration (GO:0097205) | 2.95889161 |
| 69 | intermediate filament organization (GO:0045109) | 2.95442363 |
| 70 | T cell migration (GO:0072678) | 2.91933202 |
| 71 | positive regulation of humoral immune response (GO:0002922) | 2.91828654 |
| 72 | ethanol oxidation (GO:0006069) | 2.91340175 |
| 73 | nitrogen cycle metabolic process (GO:0071941) | 2.91253512 |
| 74 | positive regulation of histone deacetylation (GO:0031065) | 2.91192930 |
| 75 | epidermal cell differentiation (GO:0009913) | 2.90791961 |
| 76 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.90452596 |
| 77 | regulation of fibrinolysis (GO:0051917) | 2.89460619 |
| 78 | endothelial cell chemotaxis (GO:0035767) | 2.88674645 |
| 79 | regulation of triglyceride catabolic process (GO:0010896) | 2.88627894 |
| 80 | regulation of protein activation cascade (GO:2000257) | 2.88440426 |
| 81 | tryptophan metabolic process (GO:0006568) | 2.88007064 |
| 82 | phospholipid homeostasis (GO:0055091) | 2.87240172 |
| 83 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.86813260 |
| 84 | protein localization to endosome (GO:0036010) | 2.86485454 |
| 85 | negative regulation of sterol transport (GO:0032372) | 2.85915831 |
| 86 | negative regulation of cholesterol transport (GO:0032375) | 2.85915831 |
| 87 | hypotonic response (GO:0006971) | 2.85753422 |
| 88 | T cell costimulation (GO:0031295) | 2.84296013 |
| 89 | protein carboxylation (GO:0018214) | 2.83626167 |
| 90 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.83626167 |
| 91 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.82369075 |
| 92 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.82045892 |
| 93 | cysteine metabolic process (GO:0006534) | 2.82018683 |
| 94 | adherens junction assembly (GO:0034333) | 2.81390382 |
| 95 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.80037616 |
| 96 | activation of Rac GTPase activity (GO:0032863) | 2.79483333 |
| 97 | lymphocyte costimulation (GO:0031294) | 2.78173999 |
| 98 | molting cycle (GO:0042303) | 2.76272023 |
| 99 | hair cycle (GO:0042633) | 2.76272023 |
| 100 | morphogenesis of an endothelium (GO:0003159) | 2.75951426 |
| 101 | endothelial tube morphogenesis (GO:0061154) | 2.75951426 |
| 102 | response to laminar fluid shear stress (GO:0034616) | 2.74632922 |
| 103 | regulation of response to interferon-gamma (GO:0060330) | 2.74395922 |
| 104 | high-density lipoprotein particle remodeling (GO:0034375) | 2.73148531 |
| 105 | regulation of complement activation (GO:0030449) | 2.71946429 |
| 106 | lysine catabolic process (GO:0006554) | 2.68227443 |
| 107 | lysine metabolic process (GO:0006553) | 2.68227443 |
| 108 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.68074929 |
| 109 | glyoxylate metabolic process (GO:0046487) | 2.67596637 |
| 110 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.67543044 |
| 111 | positive regulation of interleukin-2 production (GO:0032743) | 2.66975364 |
| 112 | sulfur amino acid catabolic process (GO:0000098) | 2.66191213 |
| 113 | regulation of extracellular matrix disassembly (GO:0010715) | 2.65168949 |
| 114 | amino-acid betaine metabolic process (GO:0006577) | 2.65014071 |
| 115 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.64284440 |
| 116 | homocysteine metabolic process (GO:0050667) | 2.64171613 |
| 117 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.62211854 |
| 118 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.60889221 |
| 119 | positive regulation of epidermis development (GO:0045684) | 2.60876375 |
| 120 | regulation of ruffle assembly (GO:1900027) | 2.60601076 |
| 121 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.59913251 |
| 122 | 2-oxoglutarate metabolic process (GO:0006103) | 2.59907313 |
| 123 | cell adhesion mediated by integrin (GO:0033627) | 2.58335188 |
| 124 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.56994230 |
| 125 | regulation of tolerance induction (GO:0002643) | 2.56018647 |
| 126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.55379279 |
| 127 | leukocyte aggregation (GO:0070486) | 2.54852606 |
| 128 | mannose metabolic process (GO:0006013) | 2.54038497 |
| 129 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.53998530 |
| 130 | bile acid metabolic process (GO:0008206) | 2.53138576 |
| 131 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.52461562 |
| 132 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.51689627 |
| 133 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.51268567 |
| 134 | plasma lipoprotein particle assembly (GO:0034377) | 2.50988622 |
| 135 | reverse cholesterol transport (GO:0043691) | 2.50713629 |
| 136 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.50483860 |
| 137 | alpha-beta T cell differentiation (GO:0046632) | 2.49473639 |
| 138 | positive regulation of receptor recycling (GO:0001921) | 2.48579689 |
| 139 | skin morphogenesis (GO:0043589) | 2.48436467 |
| 140 | alpha-beta T cell activation (GO:0046631) | 2.46307997 |
| 141 | triglyceride homeostasis (GO:0070328) | 2.46283319 |
| 142 | acylglycerol homeostasis (GO:0055090) | 2.46283319 |
| 143 | blood vessel endothelial cell migration (GO:0043534) | 2.45922011 |
| 144 | regulation of keratinocyte proliferation (GO:0010837) | 2.45645061 |
| 145 | plasma membrane repair (GO:0001778) | 2.45088195 |
| 146 | regulation of regulatory T cell differentiation (GO:0045589) | 2.44653430 |
| 147 | cell junction assembly (GO:0034329) | 2.42192224 |
| 148 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.41533118 |
| 149 | serine family amino acid catabolic process (GO:0009071) | 2.40984477 |
| 150 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.40916070 |
| 151 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.40296386 |
| 152 | cell junction organization (GO:0034330) | 2.38403958 |
| 153 | regulation of keratinocyte differentiation (GO:0045616) | 2.37426438 |
| 154 | regulation of p38MAPK cascade (GO:1900744) | 2.36119624 |
| 155 | cholesterol homeostasis (GO:0042632) | 2.35803396 |
| 156 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.34231226 |
| 157 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.33790851 |
| 158 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.33187283 |
| 159 | cell volume homeostasis (GO:0006884) | 2.33171119 |
| 160 | apoptotic process involved in morphogenesis (GO:0060561) | 2.32203430 |
| 161 | filopodium assembly (GO:0046847) | 2.31407508 |
| 162 | negative regulation of stress fiber assembly (GO:0051497) | 2.30959227 |
| 163 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.30882970 |
| 164 | keratinocyte development (GO:0003334) | 2.27599446 |
| 165 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.27189398 |
| 166 | mesodermal cell differentiation (GO:0048333) | 2.26688038 |
| 167 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.25666555 |
| 168 | negative regulation of fatty acid transport (GO:2000192) | 2.25494492 |
| 169 | negative regulation of interleukin-2 production (GO:0032703) | 2.25084162 |
| 170 | polarized epithelial cell differentiation (GO:0030859) | 2.23680781 |
| 171 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.22739038 |
| 172 | negative regulation of myotube differentiation (GO:0010832) | 2.20957822 |
| 173 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.19339240 |
| 174 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.19098166 |
| 175 | Rho protein signal transduction (GO:0007266) | 2.18890168 |
| 176 | establishment of planar polarity (GO:0001736) | 2.18480814 |
| 177 | establishment of tissue polarity (GO:0007164) | 2.18480814 |
| 178 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.18029655 |
| 179 | regulation of necroptotic process (GO:0060544) | 2.17868731 |
| 180 | cell communication involved in cardiac conduction (GO:0086065) | 2.16482001 |
| 181 | detection of bacterium (GO:0016045) | 2.15636210 |
| 182 | cell-cell junction assembly (GO:0007043) | 2.14594739 |
| 183 | cell junction maintenance (GO:0034331) | 2.14490384 |
| 184 | glomerular filtration (GO:0003094) | 2.14164786 |
| 185 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.12928169 |
| 186 | endocytic recycling (GO:0032456) | 2.11447025 |
| 187 | regulation of hair cycle (GO:0042634) | 2.11381135 |
| 188 | regulation of cardioblast differentiation (GO:0051890) | 2.10895831 |
| 189 | regulation of anoikis (GO:2000209) | 2.10502063 |
| 190 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.10368404 |
| 191 | phospholipid scrambling (GO:0017121) | 2.09620742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.06115627 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.84419166 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.27458201 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.74480734 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.61054278 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.22394329 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.14985535 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.11665223 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.08497746 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.00837072 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.76982589 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.62260120 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.54690540 |
| 14 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.52695747 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.32138575 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.29780879 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.26665570 |
| 18 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.25661584 |
| 19 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.16602949 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.10002452 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03797118 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.97416705 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.97052295 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.90814091 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.87802696 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87746262 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.84947587 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 1.80041539 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.79939017 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.77164965 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73551433 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73470930 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71881789 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71424675 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.70578373 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68062332 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.68009823 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67218237 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65002460 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.64910998 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.63508951 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61826879 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61566927 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58229623 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54001832 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52484288 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52474952 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51591210 |
| 49 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50864709 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50802777 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50522976 |
| 52 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.49514756 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.45999969 |
| 54 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.45342449 |
| 55 | ATF3_27146783_Chip-Seq_COLON_Human | 1.44087854 |
| 56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42036423 |
| 57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39831579 |
| 58 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.38361940 |
| 59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37500483 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37491898 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.37449804 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.37338689 |
| 63 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37336216 |
| 64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35782246 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35012765 |
| 66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34376531 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32771549 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32286740 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30692421 |
| 70 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.30155415 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28995618 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26851638 |
| 73 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.26461243 |
| 74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25937829 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24309261 |
| 76 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23384000 |
| 77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21893968 |
| 78 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.19602882 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19299861 |
| 80 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18687404 |
| 81 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17877999 |
| 82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17216424 |
| 83 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.17173230 |
| 84 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16633672 |
| 85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15139067 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14284011 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12959386 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12702984 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11620802 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11529865 |
| 91 | * P68_20966046_ChIP-Seq_HELA_Human | 1.11009617 |
| 92 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09758065 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07908839 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07481326 |
| 95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06812235 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05611680 |
| 97 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05331733 |
| 98 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04721332 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04475707 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03593591 |
| 101 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02561716 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02272416 |
| 103 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01405121 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00157162 |
| 105 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99180527 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98900440 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98883216 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98573897 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98171892 |
| 110 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97056469 |
| 111 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96508607 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96508607 |
| 113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96069316 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96069316 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95961474 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95425900 |
| 117 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95183975 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95002056 |
| 119 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94570646 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94523174 |
| 121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93781255 |
| 122 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93710658 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.93561835 |
| 124 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93197473 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92918415 |
| 126 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92813599 |
| 127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91973637 |
| 128 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91537325 |
| 129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91348698 |
| 130 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.91056948 |
| 131 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90066946 |
| 132 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.89669014 |
| 133 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.88906206 |
| 134 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.88528538 |
| 135 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88280308 |
| 136 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.88054842 |
| 137 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87700867 |
| 138 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.87615492 |
| 139 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86785627 |
| 140 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85211768 |
| 141 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84967777 |
| 142 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83449379 |
| 143 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83117831 |
| 144 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82474208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000579_abnormal_nail_morphology | 4.65061282 |
| 2 | MP0005360_urolithiasis | 3.93111951 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.92244741 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.52435667 |
| 5 | MP0005365_abnormal_bile_salt | 3.48962195 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.08225421 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 2.78020083 |
| 8 | MP0000566_synostosis | 2.74730401 |
| 9 | MP0005275_abnormal_skin_tensile | 2.71483107 |
| 10 | MP0003252_abnormal_bile_duct | 2.50069483 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.45128704 |
| 12 | MP0000467_abnormal_esophagus_morphology | 2.43384726 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.41935672 |
| 14 | MP0000685_abnormal_immune_system | 2.37344656 |
| 15 | MP0002098_abnormal_vibrissa_morphology | 2.31026276 |
| 16 | MP0010678_abnormal_skin_adnexa | 2.24479209 |
| 17 | MP0005409_darkened_coat_color | 2.20726015 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.19715936 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.18173821 |
| 20 | MP0004782_abnormal_surfactant_physiolog | 2.17980751 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.07231838 |
| 22 | MP0001849_ear_inflammation | 2.06261911 |
| 23 | MP0000762_abnormal_tongue_morphology | 2.05806662 |
| 24 | MP0009840_abnormal_foam_cell | 2.04786338 |
| 25 | MP0003724_increased_susceptibility_to | 2.00557205 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.96496070 |
| 27 | MP0004947_skin_inflammation | 1.92649223 |
| 28 | MP0005083_abnormal_biliary_tract | 1.91574683 |
| 29 | MP0003436_decreased_susceptibility_to | 1.88838244 |
| 30 | MP0000383_abnormal_hair_follicle | 1.87946181 |
| 31 | MP0003941_abnormal_skin_development | 1.83354492 |
| 32 | MP0000609_abnormal_liver_physiology | 1.74471744 |
| 33 | MP0002254_reproductive_system_inflammat | 1.73411541 |
| 34 | MP0001666_abnormal_nutrient_absorption | 1.72165382 |
| 35 | MP0001873_stomach_inflammation | 1.68162543 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.67951023 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.67630801 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.66738265 |
| 39 | MP0002006_tumorigenesis | 1.64566688 |
| 40 | MP0010771_integument_phenotype | 1.64131227 |
| 41 | MP0005670_abnormal_white_adipose | 1.59423934 |
| 42 | MP0001835_abnormal_antigen_presentation | 1.58260903 |
| 43 | MP0001790_abnormal_immune_system | 1.57800562 |
| 44 | MP0005387_immune_system_phenotype | 1.57800562 |
| 45 | MP0000377_abnormal_hair_follicle | 1.57123461 |
| 46 | MP0004272_abnormal_basement_membrane | 1.55502064 |
| 47 | MP0001800_abnormal_humoral_immune | 1.54829173 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.53974150 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.49505439 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.49183934 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.47680535 |
| 52 | MP0004381_abnormal_hair_follicle | 1.44641387 |
| 53 | MP0000751_myopathy | 1.44578371 |
| 54 | MP0009785_altered_susceptibility_to | 1.42619253 |
| 55 | MP0006138_congestive_heart_failure | 1.40012066 |
| 56 | MP0005671_abnormal_response_to | 1.39917580 |
| 57 | MP0002723_abnormal_immune_serum | 1.38144025 |
| 58 | MP0005025_abnormal_response_to | 1.38004715 |
| 59 | MP0001853_heart_inflammation | 1.35178384 |
| 60 | MP0001958_emphysema | 1.33359127 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.32859760 |
| 62 | MP0002405_respiratory_system_inflammati | 1.32616851 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.32142648 |
| 64 | MP0002796_impaired_skin_barrier | 1.31738592 |
| 65 | MP0001819_abnormal_immune_cell | 1.30872656 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 1.30508672 |
| 67 | MP0000678_abnormal_parathyroid_gland | 1.30050167 |
| 68 | MP0003303_peritoneal_inflammation | 1.30014184 |
| 69 | MP0003866_abnormal_defecation | 1.29744931 |
| 70 | MP0008961_abnormal_basal_metabolism | 1.28946791 |
| 71 | MP0003566_abnormal_cell_adhesion | 1.28880246 |
| 72 | MP0009931_abnormal_skin_appearance | 1.28706922 |
| 73 | MP0005076_abnormal_cell_differentiation | 1.28201439 |
| 74 | MP0005023_abnormal_wound_healing | 1.28126772 |
| 75 | MP0000703_abnormal_thymus_morphology | 1.27673330 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 1.25637112 |
| 77 | MP0005000_abnormal_immune_tolerance | 1.24854834 |
| 78 | MP0002398_abnormal_bone_marrow | 1.23551861 |
| 79 | MP0003091_abnormal_cell_migration | 1.22888128 |
| 80 | MP0001851_eye_inflammation | 1.22632491 |
| 81 | MP0009278_abnormal_bone_marrow | 1.22027850 |
| 82 | MP0005375_adipose_tissue_phenotype | 1.21380025 |
| 83 | MP0002452_abnormal_antigen_presenting | 1.20247044 |
| 84 | MP0002118_abnormal_lipid_homeostasis | 1.19207955 |
| 85 | MP0000013_abnormal_adipose_tissue | 1.19124470 |
| 86 | MP0000003_abnormal_adipose_tissue | 1.18828671 |
| 87 | MP0008260_abnormal_autophagy | 1.16705065 |
| 88 | MP0006082_CNS_inflammation | 1.16353906 |
| 89 | MP0009643_abnormal_urine_homeostasis | 1.16350308 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 1.15435336 |
| 91 | MP0004084_abnormal_cardiac_muscle | 1.15222248 |
| 92 | MP0002722_abnormal_immune_system | 1.14731343 |
| 93 | MP0001845_abnormal_inflammatory_respons | 1.14612180 |
| 94 | MP0005332_abnormal_amino_acid | 1.14326546 |
| 95 | MP0000716_abnormal_immune_system | 1.14231491 |
| 96 | MP0005666_abnormal_adipose_tissue | 1.12940176 |
| 97 | MP0003828_pulmonary_edema | 1.12289606 |
| 98 | MP0002396_abnormal_hematopoietic_system | 1.12086585 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 1.11601857 |
| 100 | MP0000689_abnormal_spleen_morphology | 1.11155400 |
| 101 | MP0004510_myositis | 1.08872908 |
| 102 | MP0009764_decreased_sensitivity_to | 1.08749069 |
| 103 | MP0009053_abnormal_anal_canal | 1.07502516 |
| 104 | MP0002419_abnormal_innate_immunity | 1.07183722 |
| 105 | MP0004130_abnormal_muscle_cell | 1.06361725 |
| 106 | MP0008469_abnormal_protein_level | 1.06326618 |
| 107 | MP0004808_abnormal_hematopoietic_stem | 1.03629394 |
| 108 | MP0004019_abnormal_vitamin_homeostasis | 1.01558366 |
| 109 | MP0005330_cardiomyopathy | 0.98489397 |
| 110 | MP0005397_hematopoietic_system_phenotyp | 0.98167414 |
| 111 | MP0001545_abnormal_hematopoietic_system | 0.98167414 |
| 112 | MP0009763_increased_sensitivity_to | 0.95529301 |
| 113 | MP0001216_abnormal_epidermal_layer | 0.93753419 |
| 114 | MP0002429_abnormal_blood_cell | 0.93167443 |
| 115 | MP0002060_abnormal_skin_morphology | 0.92882974 |
| 116 | MP0000598_abnormal_liver_morphology | 0.90529871 |
| 117 | MP0005164_abnormal_response_to | 0.90361507 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.89651413 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.89548946 |
| 120 | MP0000367_abnormal_coat/_hair | 0.89540130 |
| 121 | MP0003868_abnormal_feces_composition | 0.87276450 |
| 122 | MP0005501_abnormal_skin_physiology | 0.87054956 |
| 123 | MP0003045_fibrosis | 0.86609610 |
| 124 | MP0000427_abnormal_hair_cycle | 0.86328905 |
| 125 | MP0002933_joint_inflammation | 0.81947245 |
| 126 | MP0000465_gastrointestinal_hemorrhage | 0.81747864 |
| 127 | MP0004043_abnormal_pH_regulation | 0.81600977 |
| 128 | MP0005451_abnormal_body_composition | 0.80346006 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.80336070 |
| 130 | MP0001533_abnormal_skeleton_physiology | 0.76720625 |
| 131 | MP0003950_abnormal_plasma_membrane | 0.76614522 |
| 132 | MP0000858_altered_metastatic_potential | 0.76566270 |
| 133 | MP0005058_abnormal_lysosome_morphology | 0.76205303 |
| 134 | MP0004036_abnormal_muscle_relaxation | 0.76176999 |
| 135 | MP0005165_increased_susceptibility_to | 0.76146315 |
| 136 | MP0001879_abnormal_lymphatic_vessel | 0.75535147 |
| 137 | MP0004858_abnormal_nervous_system | 0.75395286 |
| 138 | MP0002148_abnormal_hypersensitivity_rea | 0.74509996 |
| 139 | MP0001191_abnormal_skin_condition | 0.73883839 |
| 140 | MP0000627_abnormal_mammary_gland | 0.72947908 |
| 141 | MP0000249_abnormal_blood_vessel | 0.72907750 |
| 142 | MP0000537_abnormal_urethra_morphology | 0.72200592 |
| 143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71959832 |
| 144 | MP0001243_abnormal_dermal_layer | 0.71623182 |
| 145 | MP0002234_abnormal_pharynx_morphology | 0.70579043 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.68267059 |
| 147 | MP0000733_abnormal_muscle_development | 0.68082300 |
| 148 | MP0002896_abnormal_bone_mineralization | 0.66490064 |
| 149 | MP0004883_abnormal_blood_vessel | 0.65634661 |
| 150 | MP0004087_abnormal_muscle_fiber | 0.65156701 |
| 151 | MP0005166_decreased_susceptibility_to | 0.64895261 |
| 152 | MP0002998_abnormal_bone_remodeling | 0.63116341 |
| 153 | MP0010630_abnormal_cardiac_muscle | 0.63071113 |
| 154 | MP0005377_hearing/vestibular/ear_phenot | 0.62903226 |
| 155 | MP0003878_abnormal_ear_physiology | 0.62903226 |
| 156 | MP0002972_abnormal_cardiac_muscle | 0.58294899 |
| 157 | MP0003638_abnormal_response/metabolism_ | 0.57220747 |
| 158 | MP0002332_abnormal_exercise_endurance | 0.56349770 |
| 159 | MP0000767_abnormal_smooth_muscle | 0.55779037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Plantar hyperkeratosis (HP:0007556) | 5.48558635 |
| 2 | Abnormality of nail color (HP:0100643) | 5.46766554 |
| 3 | Onycholysis (HP:0001806) | 4.78437842 |
| 4 | Fragile nails (HP:0001808) | 4.77415785 |
| 5 | Thick nail (HP:0001805) | 4.75710219 |
| 6 | Atrophic scars (HP:0001075) | 4.64719233 |
| 7 | T lymphocytopenia (HP:0005403) | 4.63698783 |
| 8 | Palmoplantar hyperkeratosis (HP:0000972) | 4.57692198 |
| 9 | Alopecia of scalp (HP:0002293) | 4.54356407 |
| 10 | Abnormality of T cell number (HP:0011839) | 4.46079194 |
| 11 | Deep venous thrombosis (HP:0002625) | 4.35221085 |
| 12 | Palmar hyperkeratosis (HP:0010765) | 4.22545584 |
| 13 | Pustule (HP:0200039) | 3.97952296 |
| 14 | Nail dystrophy (HP:0008404) | 3.96116785 |
| 15 | Xanthomatosis (HP:0000991) | 3.78577042 |
| 16 | Pili torti (HP:0003777) | 3.75295830 |
| 17 | Intrahepatic cholestasis (HP:0001406) | 3.73060093 |
| 18 | Abnormality of the nasal mucosa (HP:0000433) | 3.63874286 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.60975198 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.57704108 |
| 21 | Abnormal hair laboratory examination (HP:0003328) | 3.50563070 |
| 22 | Spontaneous hematomas (HP:0007420) | 3.49381830 |
| 23 | Abnormal blistering of the skin (HP:0008066) | 3.40298657 |
| 24 | Distal lower limb muscle weakness (HP:0009053) | 3.34476991 |
| 25 | Esophageal varix (HP:0002040) | 3.33085694 |
| 26 | Hyperlipoproteinemia (HP:0010980) | 3.32582733 |
| 27 | Lip pit (HP:0100267) | 3.32186777 |
| 28 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.27256509 |
| 29 | Nasal polyposis (HP:0100582) | 3.21220245 |
| 30 | Abnormality of the fingertips (HP:0001211) | 3.21152750 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.20329817 |
| 32 | Hypotrichosis (HP:0001006) | 3.20282934 |
| 33 | Joint hemorrhage (HP:0005261) | 3.16020648 |
| 34 | Myocardial infarction (HP:0001658) | 3.12027721 |
| 35 | Fragile skin (HP:0001030) | 3.08122784 |
| 36 | Complement deficiency (HP:0004431) | 3.03827037 |
| 37 | Chronic otitis media (HP:0000389) | 3.03217203 |
| 38 | Ridged nail (HP:0001807) | 3.03108901 |
| 39 | Abnormality of T cells (HP:0002843) | 2.98923143 |
| 40 | Abnormal platelet volume (HP:0011876) | 2.92638494 |
| 41 | Hypoplasia of dental enamel (HP:0006297) | 2.89774926 |
| 42 | Prolonged partial thromboplastin time (HP:0003645) | 2.88902608 |
| 43 | Recurrent fungal infections (HP:0002841) | 2.82601319 |
| 44 | Combined immunodeficiency (HP:0005387) | 2.81584193 |
| 45 | Abnormality of the salivary glands (HP:0010286) | 2.81019303 |
| 46 | Increased mean platelet volume (HP:0011877) | 2.80274791 |
| 47 | Hypobetalipoproteinemia (HP:0003563) | 2.80036233 |
| 48 | Woolly hair (HP:0002224) | 2.77587643 |
| 49 | Severe combined immunodeficiency (HP:0004430) | 2.74172448 |
| 50 | Polycythemia (HP:0001901) | 2.73446274 |
| 51 | Ventricular tachycardia (HP:0004756) | 2.73045539 |
| 52 | Recurrent viral infections (HP:0004429) | 2.70118382 |
| 53 | Stomatitis (HP:0010280) | 2.69197860 |
| 54 | Eczematoid dermatitis (HP:0000976) | 2.64816837 |
| 55 | Broad face (HP:0000283) | 2.63935935 |
| 56 | Distal lower limb amyotrophy (HP:0008944) | 2.63822795 |
| 57 | Natal tooth (HP:0000695) | 2.61800906 |
| 58 | Gingival bleeding (HP:0000225) | 2.61181867 |
| 59 | Pterygium (HP:0001059) | 2.61075635 |
| 60 | Abnormality of the common coagulation pathway (HP:0010990) | 2.58836815 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.56839404 |
| 62 | Popliteal pterygium (HP:0009756) | 2.55831542 |
| 63 | Increased connective tissue (HP:0009025) | 2.55376766 |
| 64 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51337587 |
| 65 | Panhypogammaglobulinemia (HP:0003139) | 2.50484749 |
| 66 | Hyperactive renin-angiotensin system (HP:0000841) | 2.49385798 |
| 67 | Hyperammonemia (HP:0001987) | 2.47524285 |
| 68 | Eosinophilia (HP:0001880) | 2.46492472 |
| 69 | Interstitial pulmonary disease (HP:0006530) | 2.45436401 |
| 70 | Corneal erosion (HP:0200020) | 2.45288265 |
| 71 | Advanced eruption of teeth (HP:0006288) | 2.44732138 |
| 72 | Epistaxis (HP:0000421) | 2.44652523 |
| 73 | Hypoplasia of the thymus (HP:0000778) | 2.43123480 |
| 74 | Obstructive sleep apnea (HP:0002870) | 2.42073870 |
| 75 | Joint swelling (HP:0001386) | 2.40457746 |
| 76 | Epidermoid cyst (HP:0200040) | 2.38365594 |
| 77 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.36894846 |
| 78 | Menorrhagia (HP:0000132) | 2.35608467 |
| 79 | Abnormality of secondary sexual hair (HP:0009888) | 2.34792733 |
| 80 | Abnormality of the axillary hair (HP:0100134) | 2.34792733 |
| 81 | Sparse scalp hair (HP:0002209) | 2.34440265 |
| 82 | Hypercholesterolemia (HP:0003124) | 2.34098852 |
| 83 | Increased IgE level (HP:0003212) | 2.33230190 |
| 84 | Right ventricular cardiomyopathy (HP:0011663) | 2.32795313 |
| 85 | Flat acetabular roof (HP:0003180) | 2.32604972 |
| 86 | Palmoplantar keratoderma (HP:0000982) | 2.31477675 |
| 87 | Hematochezia (HP:0002573) | 2.30522401 |
| 88 | Ankyloglossia (HP:0010296) | 2.29752718 |
| 89 | Hypolipoproteinemia (HP:0010981) | 2.29356000 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.28905640 |
| 91 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.28905640 |
| 92 | Selective tooth agenesis (HP:0001592) | 2.28092194 |
| 93 | Erythema (HP:0010783) | 2.27585068 |
| 94 | Hypoalphalipoproteinemia (HP:0003233) | 2.25289860 |
| 95 | Cerebral aneurysm (HP:0004944) | 2.25255364 |
| 96 | Prolonged bleeding time (HP:0003010) | 2.24647449 |
| 97 | Aortic aneurysm (HP:0004942) | 2.23998424 |
| 98 | Abnormality of complement system (HP:0005339) | 2.21882882 |
| 99 | Acanthosis nigricans (HP:0000956) | 2.21148311 |
| 100 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.21070798 |
| 101 | Granulocytopenia (HP:0001913) | 2.19592240 |
| 102 | Oral leukoplakia (HP:0002745) | 2.19101263 |
| 103 | Aplasia cutis congenita (HP:0001057) | 2.18492657 |
| 104 | Hyporeflexia of lower limbs (HP:0002600) | 2.16127028 |
| 105 | Hyperglycinuria (HP:0003108) | 2.16011549 |
| 106 | Recurrent bronchitis (HP:0002837) | 2.15904390 |
| 107 | Exercise-induced myalgia (HP:0003738) | 2.15660511 |
| 108 | Axonal loss (HP:0003447) | 2.14206731 |
| 109 | Cervical subluxation (HP:0003308) | 2.13455069 |
| 110 | Fat malabsorption (HP:0002630) | 2.13178757 |
| 111 | Thin bony cortex (HP:0002753) | 2.13016625 |
| 112 | Milia (HP:0001056) | 2.12886346 |
| 113 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.12803940 |
| 114 | Abnormality of eosinophils (HP:0001879) | 2.10521967 |
| 115 | Spastic diplegia (HP:0001264) | 2.09843884 |
| 116 | Hemorrhage of the eye (HP:0011885) | 2.09406935 |
| 117 | Ketosis (HP:0001946) | 2.06637952 |
| 118 | Hypoglycemic coma (HP:0001325) | 2.05623768 |
| 119 | Autoimmune hemolytic anemia (HP:0001890) | 2.02662509 |
| 120 | Broad metatarsal (HP:0001783) | 2.02103669 |
| 121 | Sparse eyelashes (HP:0000653) | 2.01396691 |
| 122 | Oligodontia (HP:0000677) | 2.01146794 |
| 123 | Ectopia lentis (HP:0001083) | 1.98902873 |
| 124 | Vascular calcification (HP:0004934) | 1.98537495 |
| 125 | Pulmonary embolism (HP:0002204) | 1.98449235 |
| 126 | Inflammation of the large intestine (HP:0002037) | 1.98389685 |
| 127 | Gout (HP:0001997) | 1.98385513 |
| 128 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.98305386 |
| 129 | Abnormality of glycine metabolism (HP:0010895) | 1.98305386 |
| 130 | Hepatitis (HP:0012115) | 1.95558688 |
| 131 | Ureteral stenosis (HP:0000071) | 1.95301589 |
| 132 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.93957328 |
| 133 | Anonychia (HP:0001798) | 1.93551541 |
| 134 | Gastrointestinal inflammation (HP:0004386) | 1.93313632 |
| 135 | Hepatocellular carcinoma (HP:0001402) | 1.91895711 |
| 136 | Focal segmental glomerulosclerosis (HP:0000097) | 1.91605826 |
| 137 | Abnormality of the neuromuscular junction (HP:0003398) | 1.91161228 |
| 138 | Fatigable weakness (HP:0003473) | 1.91161228 |
| 139 | Leukocytosis (HP:0001974) | 1.90737086 |
| 140 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.89630532 |
| 141 | Difficulty climbing stairs (HP:0003551) | 1.89265162 |
| 142 | Hypoplastic labia majora (HP:0000059) | 1.88955920 |
| 143 | Abnormal platelet function (HP:0011869) | 1.88153491 |
| 144 | Impaired platelet aggregation (HP:0003540) | 1.88153491 |
| 145 | Abnormality of purine metabolism (HP:0004352) | 1.87862724 |
| 146 | Frequent falls (HP:0002359) | 1.86996783 |
| 147 | Abnormality of the intrinsic pathway (HP:0010989) | 1.84963139 |
| 148 | Dry hair (HP:0011359) | 1.84539458 |
| 149 | Abnormality of oral frenula (HP:0000190) | 1.82584764 |
| 150 | Aneurysm (HP:0002617) | 1.82577448 |
| 151 | Sudden death (HP:0001699) | 1.82552245 |
| 152 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.82158177 |
| 153 | Chronic diarrhea (HP:0002028) | 1.81699042 |
| 154 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80265658 |
| 155 | Upper limb amyotrophy (HP:0009129) | 1.78925720 |
| 156 | Distal upper limb amyotrophy (HP:0007149) | 1.78925720 |
| 157 | Cheilitis (HP:0100825) | 1.78187950 |
| 158 | Abnormality of T cell physiology (HP:0011840) | 1.78020556 |
| 159 | Cardiovascular calcification (HP:0011915) | 1.77778824 |
| 160 | Asymmetric septal hypertrophy (HP:0001670) | 1.77556999 |
| 161 | Mitral valve prolapse (HP:0001634) | 1.76970055 |
| 162 | Blepharitis (HP:0000498) | 1.76452664 |
| 163 | Neonatal death (HP:0003811) | 1.76387685 |
| 164 | Muscle fiber splitting (HP:0003555) | 1.75927872 |
| 165 | Bronchomalacia (HP:0002780) | 1.75067950 |
| 166 | Polygenic inheritance (HP:0010982) | 1.74746888 |
| 167 | Amelogenesis imperfecta (HP:0000705) | 1.74628432 |
| 168 | Abnormality of the labia majora (HP:0012881) | 1.74184079 |
| 169 | Malnutrition (HP:0004395) | 1.73154692 |
| 170 | Abnormality of nucleobase metabolism (HP:0010932) | 1.73103485 |
| 171 | Laryngomalacia (HP:0001601) | 1.73097688 |
| 172 | Conjunctival telangiectasia (HP:0000524) | 1.72873883 |
| 173 | Dehydration (HP:0001944) | 1.71675965 |
| 174 | Nephritis (HP:0000123) | 1.71383754 |
| 175 | Abnormality of permanent molar morphology (HP:0011071) | 1.71256209 |
| 176 | Abnormality of the dental root (HP:0006486) | 1.71256209 |
| 177 | Taurodontia (HP:0000679) | 1.71256209 |
| 178 | Short nail (HP:0001799) | 1.70115339 |
| 179 | Ectropion (HP:0000656) | 1.69488949 |
| 180 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.68737059 |
| 181 | Hyperkalemia (HP:0002153) | 1.68362132 |
| 182 | Glomerulosclerosis (HP:0000096) | 1.68151151 |
| 183 | Absent eyelashes (HP:0000561) | 1.67917668 |
| 184 | Arterial tortuosity (HP:0005116) | 1.64412750 |
| 185 | Systemic lupus erythematosus (HP:0002725) | 1.63328562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 4.10156554 |
| 2 | MAP4K1 | 3.59901193 |
| 3 | MET | 3.44118653 |
| 4 | PKN2 | 2.97128109 |
| 5 | TXK | 2.73408250 |
| 6 | TYK2 | 2.42324477 |
| 7 | STK10 | 2.34547916 |
| 8 | TGFBR2 | 2.32278481 |
| 9 | ITK | 2.30113495 |
| 10 | JAK3 | 2.23642532 |
| 11 | TIE1 | 2.22772681 |
| 12 | ZAP70 | 2.20709954 |
| 13 | FGFR3 | 2.17413645 |
| 14 | TTN | 2.17032716 |
| 15 | IKBKE | 2.11549707 |
| 16 | MAP3K6 | 2.06588624 |
| 17 | NLK | 2.04210267 |
| 18 | EEF2K | 1.99213929 |
| 19 | GRK6 | 1.96392617 |
| 20 | TRIB3 | 1.94207587 |
| 21 | MAP3K10 | 1.93102934 |
| 22 | MAPK15 | 1.77583533 |
| 23 | LMTK2 | 1.76758631 |
| 24 | EPHB2 | 1.75698029 |
| 25 | ERN1 | 1.73306697 |
| 26 | SIK1 | 1.67383769 |
| 27 | FLT3 | 1.66278820 |
| 28 | PRPF4B | 1.64703170 |
| 29 | JAK1 | 1.64335314 |
| 30 | EPHB1 | 1.64267363 |
| 31 | MAP3K14 | 1.62734806 |
| 32 | KDR | 1.57280610 |
| 33 | MAP3K13 | 1.49797078 |
| 34 | PTK6 | 1.46187781 |
| 35 | MAP3K7 | 1.44403838 |
| 36 | FGFR2 | 1.37979736 |
| 37 | SMG1 | 1.37227242 |
| 38 | TBK1 | 1.34515109 |
| 39 | LRRK2 | 1.31457862 |
| 40 | TEC | 1.30370376 |
| 41 | MAP3K2 | 1.30202250 |
| 42 | EPHA2 | 1.26102126 |
| 43 | CSK | 1.23539078 |
| 44 | MAP2K3 | 1.21339277 |
| 45 | FER | 1.19943121 |
| 46 | CDC42BPA | 1.18759891 |
| 47 | JAK2 | 1.12840374 |
| 48 | RIPK1 | 1.11080337 |
| 49 | LCK | 1.11052497 |
| 50 | PAK4 | 1.10676411 |
| 51 | MST4 | 1.08472937 |
| 52 | CDK12 | 1.07645603 |
| 53 | PRKCH | 1.06922711 |
| 54 | STK38 | 1.06905303 |
| 55 | NTRK1 | 1.06320327 |
| 56 | MYLK | 1.05400564 |
| 57 | HCK | 1.04378595 |
| 58 | EPHA3 | 1.04007642 |
| 59 | TGFBR1 | 1.03434563 |
| 60 | MAP3K3 | 0.97438724 |
| 61 | LATS2 | 0.94759150 |
| 62 | PDGFRB | 0.91689117 |
| 63 | PRKCQ | 0.90812987 |
| 64 | BTK | 0.90587637 |
| 65 | BMX | 0.88312019 |
| 66 | TRPM7 | 0.87104149 |
| 67 | ICK | 0.84695809 |
| 68 | CHUK | 0.84138871 |
| 69 | BCKDK | 0.83311243 |
| 70 | RPS6KA4 | 0.81200817 |
| 71 | PTK2 | 0.80948311 |
| 72 | IKBKB | 0.80189160 |
| 73 | MAP2K6 | 0.79471718 |
| 74 | MAP3K1 | 0.79217087 |
| 75 | MST1R | 0.78021295 |
| 76 | RPS6KB2 | 0.77910674 |
| 77 | MARK3 | 0.76745426 |
| 78 | RPS6KA2 | 0.75981110 |
| 79 | SIK3 | 0.73592809 |
| 80 | MAPK11 | 0.73423453 |
| 81 | MAPK7 | 0.73178752 |
| 82 | NME2 | 0.72014856 |
| 83 | MAPK12 | 0.71267607 |
| 84 | KIT | 0.70459688 |
| 85 | NME1 | 0.70299743 |
| 86 | SGK3 | 0.68266655 |
| 87 | MAP3K9 | 0.68188175 |
| 88 | PDGFRA | 0.68068563 |
| 89 | PIM1 | 0.66976037 |
| 90 | DMPK | 0.64598678 |
| 91 | PRKD2 | 0.64166554 |
| 92 | TYRO3 | 0.63239128 |
| 93 | CDK6 | 0.63138991 |
| 94 | PDPK1 | 0.63025341 |
| 95 | FGFR1 | 0.60614235 |
| 96 | TESK1 | 0.60154382 |
| 97 | CAMK1D | 0.58992322 |
| 98 | SIK2 | 0.56595227 |
| 99 | RPS6KL1 | 0.56472456 |
| 100 | RPS6KC1 | 0.56472456 |
| 101 | PRKAA2 | 0.56080187 |
| 102 | ERBB2 | 0.53247435 |
| 103 | MARK2 | 0.51981894 |
| 104 | PRKD1 | 0.49664709 |
| 105 | MTOR | 0.49179367 |
| 106 | TAOK3 | 0.48968340 |
| 107 | SYK | 0.48847645 |
| 108 | ARAF | 0.47916210 |
| 109 | NEK9 | 0.47227759 |
| 110 | MUSK | 0.45260499 |
| 111 | RET | 0.44840041 |
| 112 | PDK1 | 0.43125496 |
| 113 | DYRK1B | 0.42963170 |
| 114 | MAPKAPK3 | 0.40397209 |
| 115 | DDR2 | 0.40069129 |
| 116 | IRAK3 | 0.40021515 |
| 117 | PRKG2 | 0.39525249 |
| 118 | IRAK4 | 0.38538628 |
| 119 | PHKG1 | 0.38487667 |
| 120 | PHKG2 | 0.38487667 |
| 121 | STK4 | 0.38323437 |
| 122 | CAMK1G | 0.37970169 |
| 123 | CDK4 | 0.37425123 |
| 124 | STK24 | 0.37354900 |
| 125 | SGK2 | 0.36899136 |
| 126 | EGFR | 0.36264840 |
| 127 | HIPK2 | 0.36044585 |
| 128 | IGF1R | 0.35804605 |
| 129 | PIM2 | 0.35699230 |
| 130 | LATS1 | 0.35598861 |
| 131 | MAPK4 | 0.35265260 |
| 132 | TNK2 | 0.35058319 |
| 133 | TAOK1 | 0.34899373 |
| 134 | MAPKAPK2 | 0.33842334 |
| 135 | RPS6KA6 | 0.31914687 |
| 136 | STK38L | 0.31654762 |
| 137 | PTK2B | 0.31224862 |
| 138 | ABL2 | 0.30037093 |
| 139 | KSR2 | 0.29846989 |
| 140 | PRKCI | 0.29679002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.15055256 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.79592989 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.62736732 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.44178448 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32666641 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.21873015 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.16854732 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.15777314 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.00094823 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.97897111 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.97497602 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.97400830 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.87914683 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78628984 |
| 15 | Lysine degradation_Homo sapiens_hsa00310 | 1.65663187 |
| 16 | ABC transporters_Homo sapiens_hsa02010 | 1.63556937 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.62077444 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60621955 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58448104 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.47236518 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.47051815 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.46757705 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41972323 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.41286265 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.40966603 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38878972 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38015823 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.36043783 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.28281392 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.24303948 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21941220 |
| 32 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.20818545 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.20011503 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19312303 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.14158973 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14091667 |
| 37 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.13067876 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12864547 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.12628193 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.12186608 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.12082509 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.11191868 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10833174 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10468529 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07895966 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07453159 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.05220251 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04662361 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 1.03964624 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 1.03800511 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01590317 |
| 52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.99991898 |
| 53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.99938499 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99291962 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.99108939 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98823172 |
| 57 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.98813930 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98369109 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98341931 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97628383 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.96797236 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95788794 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.95476951 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94157401 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94024710 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93693722 |
| 67 | Bladder cancer_Homo sapiens_hsa05219 | 0.92631753 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92607431 |
| 69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91853226 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91315901 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90874488 |
| 72 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89564316 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.87466009 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.86865738 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85102766 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84913523 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83833105 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81521579 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81060319 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78811499 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.78398585 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78248604 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.77901513 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77652332 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77562961 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74450172 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72613775 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72228104 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.72160702 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72043920 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71658286 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71616548 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71185790 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70711044 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69276411 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69214328 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68136372 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67529323 |
| 99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67486026 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66686621 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.65495863 |
| 102 | Influenza A_Homo sapiens_hsa05164 | 0.65466306 |
| 103 | Axon guidance_Homo sapiens_hsa04360 | 0.65115017 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64965223 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63813929 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.63594821 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63562776 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63422057 |
| 109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62242287 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62206322 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61776587 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60989717 |
| 113 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59722551 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59240387 |
| 115 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59101007 |
| 116 | Renin secretion_Homo sapiens_hsa04924 | 0.57743277 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55420193 |
| 118 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54741993 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54574112 |
| 120 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54406322 |
| 121 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54171330 |
| 122 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50498486 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50486032 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.49953639 |
| 125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49318053 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49303687 |
| 127 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49284379 |
| 128 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.49278815 |
| 129 | Hepatitis B_Homo sapiens_hsa05161 | 0.47763704 |
| 130 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47689554 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47533477 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47151304 |
| 133 | Lysosome_Homo sapiens_hsa04142 | 0.46777958 |
| 134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46724408 |
| 135 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46552523 |
| 136 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44489991 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44281250 |
| 138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43668958 |
| 139 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43641961 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43393792 |
| 141 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42868020 |
| 142 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42798456 |
| 143 | Focal adhesion_Homo sapiens_hsa04510 | 0.42665901 |
| 144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42627193 |
| 145 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.40151959 |
| 146 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39864072 |
| 147 | Apoptosis_Homo sapiens_hsa04210 | 0.38814991 |
| 148 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38581084 |
| 149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37456147 |
| 150 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36520481 |
| 151 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36227351 |
| 152 | Amoebiasis_Homo sapiens_hsa05146 | 0.35219965 |
| 153 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34403193 |
| 154 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32631329 |

